Search results
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 6 days agoThe study confirmed the vaccine's effectiveness and its importance to control of the disease, while...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 1 day agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
Daily Telegraph· 1 day agoAstraZeneca had been unable to identify the cause of the clots and the Government bought its Covid...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 7 days agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
Biodexa gains license for polyposis asset as stock more than doubles
Pharmaceutical Technology via Yahoo Finance· 3 days agoIn the trial, thirty patients with FAP who are undergoing endoscopic surveillance will be given...
We May Be Facing an Epidemic of This Brain Disease
Mercola· 3 days agoAccording to mounting data, one of the more serious side effects of the COVID mRNA jabs appears to be dementia, and worse yet, this previously untransmissible disease may now be “contagious, ...
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 3 days agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound
BioPharma Dive via Yahoo Finance· 2 days agoLarge and small drugmakers are vying for a piece of what analysts view as one of the biggest market...
CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoCureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript April 24, 2024 CureVac N.V. isn’t one of...
Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc. (Fed. Cir. 2024) | JD Supra
JD Supra· 7 days agoPharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc. The majority opinion raises issues in its invalidity analysis regarding the extent to which the prior art should be required to disclose ...